About US

The Simulator Company is a pioneering British enterprise based in London that is dedicated to revolutionising clinical training through advanced simulation technology.

 

Established in October 2019 by Babita Haval and Sagar Haval, we proudly stand as the first UK company to manufacture cutting-edge ECLS (Extracorporeal Life Support) manikin-based simulators. Our simulators are meticulously engineered to replicate realistic clinical scenarios, providing an unparalleled training experience for healthcare professionals.

​

Our journey has been marked by relentless innovation and a commitment to pushing the boundaries of medical simulation.

 

Here's a timeline of our product development and milestones:

​

• Jan 2017 to October 2021: Research and development of the E-SIM and E-SIM Pro Simulators, laying the foundation for the next generation of ECMO simulation technology.

• October 2021: We opened the pre-order phase, receiving our first global orders in November 2021, demonstrating the strong market demand for our groundbreaking simulators.

​

• May 2022: The official company and product launch took place online and at an international conference in London. We introduced the following products:

  • E-SIM:  An ECMO Cannulation and Perfusion Simulator, featuring four times more capabilities than any other ECMO Cannulation Simulator available.

  • E-SIM Pro:  An ECMO Cannulation, Perfusion, and Perfusion Troubleshooting Simulator, with eleven times more features than its closest competitor.

​

• April 2023: We expanded our product line with the launch of:

  • E-SIM Pro 2: An advanced simulator that integrates ECMO Cannulation, Perfusion, Troubleshooting, Ventilation, and Whole-Body Ultrasound, offering sixteen times more features than any other ECMO Cannulation Simulator worldwide.

  • U-SIM:  The world’s first Whole-Body Ultrasound Simulator integrated into an ECMO Cannulation Simulator, debuting alongside the E-SIM Pro 2.

  • LVAD Mini: The world’s first LVAD (Left Ventricular Assist Device) Haemodynamics Training Simulator.

  • E-SIM Mini:  The world’s most portable and versatile ECMO Cannulation, Perfusion, and Perfusion Troubleshooting Simulator.

​

• April 2024: We continued our innovation streak with the launch of:

  • CAN-SIM:  A simple yet powerful ECMO Cannulation and Perfusion Simulator.

  • Pump-E: The world’s first ECMO Pump Simulator.

  • H-SIM: The world’s first Artificial Intelligence-integrated ECMO Haemodynamics Simulator.

​

• September 2024: We continued innovations with the launch of:

  • E-SIM Pro 2 Plus: The World's first Complete ECLS Simulator powered by Artificial Intelligence. ​

​

Our products are designed not only to meet but to anticipate the evolving clinical training needs associated with Advanced Circulatory Life Support therapies. By simulating the most challenging clinical scenarios, our simulators enhance technical proficiency and prepare trainees for real-world medical situations.

​

Recognitions

​

Our commitment to excellence and innovation has been recognized with several prestigious awards that underscore our impact on the medical simulation industry and our contribution to healthcare education:

• Highly Commended - New Business of the Year 2022 by Lloyds Bank British Business Excellence Awards, acknowledging our strong market entrance and immediate impact.

• Best in Innovation of the Year 2022 by the British Chamber of Commerce Awards, recognizing our pioneering technologies that set new standards in medical simulation.

• Best in Innovation of the Year 2023 by the British Business Champions Awards, further solidifying our position as leaders in creative and effective solutions for medical training.

• Finalists in Best in Innovation of the Year 2023 by the Lloyds Bank British Business Excellence Awards, highlighting our continued excellence and leadership in innovation within the business community.

​

At The Simulator Company, we are driven by a passion for innovation in the field of extracorporeal circulation.

 

We firmly believe that through the power of simulation, we can contribute to saving lives and improving patient outcomes.